Pastore, A., Jurinovic, V., Kridel, R., Hoster, E., Staiger, A. M., Szczepanowski, M., . . . Weigert, O. (2015). Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: A retrospective analysis of a prospective clinical trial and validation in a population-based registry. The lancet oncology, 16(9), 1111-1122. https://doi.org/10.1016/S1470-2045(15)00169-2
Chicago-Zitierstil (17. Ausg.)Pastore, Alessandro, et al. "Integration of Gene Mutations in Risk Prognostication for Patients Receiving First-line Immunochemotherapy for Follicular Lymphoma: A Retrospective Analysis of a Prospective Clinical Trial and Validation in a Population-based Registry." The Lancet Oncology 16, no. 9 (2015): 1111-1122. https://doi.org/10.1016/S1470-2045(15)00169-2.
MLA-Zitierstil (9. Ausg.)Pastore, Alessandro, et al. "Integration of Gene Mutations in Risk Prognostication for Patients Receiving First-line Immunochemotherapy for Follicular Lymphoma: A Retrospective Analysis of a Prospective Clinical Trial and Validation in a Population-based Registry." The Lancet Oncology, vol. 16, no. 9, 2015, pp. 1111-1122, https://doi.org/10.1016/S1470-2045(15)00169-2.